Quick10K

⚲

Axalta Coating Systems

Filings

10-Q	2021-03-31	Filed 2021-04-26
10-K	2020-12-31	Filed 2021-02-18
10-Q	2020-09-30	Filed 2020-10-26
10-Q	2020-06-30	Filed 2020-07-29
10-Q	2020-03-31	Filed 2020-05-06
10-K	2019-12-31	Filed 2020-02-19
10-Q	2019-09-30	Filed 2019-10-25
10-Q	2019-06-30	Filed 2019-07-25
10-Q	2019-03-31	Filed 2019-04-25
10-K	2018-12-31	Filed 2019-02-26
10-Q	2018-09-30	Filed 2018-10-25
10-Q	2018-06-30	Filed 2018-07-26
10-Q	2018-03-31	Filed 2018-04-25
10-K	2017-12-31	Filed 2018-02-22
10-Q	2017-09-30	Filed 2017-10-26
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-04-26
10-K	2016-12-31	Filed 2017-02-28
10-Q	2016-09-30	Filed 2016-10-27
10-Q	2016-06-30	Filed 2016-07-27
10-Q	2016-03-31	Filed 2016-04-28
10-K	2015-12-31	Filed 2016-02-29
10-Q	2015-09-30	Filed 2015-10-30
10-Q	2015-06-30	Filed 2015-08-04
10-Q	2015-03-31	Filed 2015-05-06
10-K	2014-12-31	Filed 2015-03-13
10-Q	2014-09-30	Filed 2014-11-14

Reports

8-K	2021-02-17
8-K	2021-02-01
8-K	2020-11-24
8-K	2020-11-09
8-K	2020-11-09
8-K	2020-10-21
8-K	2020-09-22
8-K	2020-08-24
8-K	2020-07-29
8-K	2020-07-03
8-K	2020-06-16
8-K	2020-06-15
8-K	2020-06-01
8-K	2020-06-01
8-K	2020-05-05
8-K	2020-04-29
8-K	2020-04-27
8-K	2020-03-31
8-K	2020-03-24
8-K	2020-01-30
8-K	2019-11-04
8-K	2019-10-24
8-K	2019-09-08
8-K	2019-08-07
8-K	2019-07-25
8-K	2019-06-28
8-K	2019-06-24
8-K	2019-06-19
8-K	2019-05-29
8-K	2019-05-06
8-K	2019-05-02
8-K	2019-04-30
8-K	2019-04-24
8-K	2019-04-24
8-K	2019-03-27
8-K	2019-02-27
8-K	2019-01-31
8-K	2019-01-30
8-K	2018-12-19
8-K	2018-12-10
8-K	2018-11-15
8-K	2018-10-31
8-K	2018-10-26
8-K	2018-10-25
8-K	2018-10-18
8-K	2018-10-07
8-K	2018-08-06
8-K	2018-07-25
8-K	2018-07-25
8-K	2018-05-07
8-K	2018-05-02
8-K	2018-04-25
8-K	2018-04-11
8-K	2018-03-28
8-K	2018-03-08
8-K	2018-02-22
8-K	2018-02-06

Axalta Coating Systems Financials

AXTA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	223	308	412		420	480	528	538	442	485	592	773	603	554	591	696	519	585	770
Accounts Receivable	664	703	684		681	720	715	640	735	841	767	748	824	862	834	740	810	872	834
Inventory	541	555	541		543	520	546	530	559	580	624	609	642	600	619	613	627	611	597
PP&E	1,776	1,835	1,812		1,895	1,917	1,975	1,933	2,005	2,098	2,148	2,194	2,270	2,204	2,226	2,219	2,225	2,248	2,200
Assets	5,898	5,931	5,899	153	5,833	5,836	6,142	5,855	5,960	6,657	6,813	6,832	6,947	6,696	6,761	6,676	6,673	6,693	6,690
Accounts Payable	458	446	444		420	438	469	474	457	490	545	555	570	538	534	523	531	508	495
Long-Term Debt	3,626	3,642	3,631		3,517	3,399	3,527	3,304	3,335	3,876	3,939	3,949	3,992	3,914	3,921	3,894	3,900	3,902	3,858
Liabilities	4,850	4,819	4,795	42	4,632	4,581	4,812	4,597	4,577	5,266	5,378	5,424	5,423	5,290	5,415	5,365	5,394	5,386	5,350
Stockholders' Equity	979	1,042	1,036		1,134	1,186	1,210	1,136	1,260	1,266	1,309	1,276	1,421	1,304	1,243	1,205	1,206	1,252	1,286


Income Statement ($MM)	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	998	1,101	1,005	-2,952	962	1,072	1,029	1,035	1,014	1,095	1,096	1,172	1,172	1,212	1,146	1,166	1,119	1,158	1,107
Cost of Revenue																777	751	748	707
Gross Profit																388	368	409	400
R&D	13	13	13		13	14	15	16	16	16	17	17	19	18	17		18	18	17
SG&A	213	246	219		219	238	242	263	225	246	246	280	228	225	293		218	206	232
Tax	1	30	18		15	20	-1	6	10	10	2	120	12	22	14		14	18	18
Net Income	47	-24	36		31	50	-10	-34	66	-19	56	-56	71	77	-12	77	44	100	66


Cash Flow ($MM)	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	-99	104	159		-18	197	144	236	-5	99	212	234	-21	142	124		-58	127
Cash Investing	-30	-27	-54		-43	-24	-138	-52	-89	-506	-51	-43	-145	-30	-30		-19	-15
Cash Financing	-20	43	7		-2	-106	43	-167	-5	442	-57	-13	-14	-143	-55		-102	-46